- £81.91bn
- £95.80bn
- £32.67bn
REG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - JPMorgan Inv. Trusts - Ten Largest Investments
AnnouncementREG - GlaxoSmithKline PLC - Transfer of Treasury Shares
AnnouncementREG - GlaxoSmithKline PLC - Benlysta approved in China for Lupus Nephritis
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Final Results
AnnouncementREG - GlaxoSmithKline PLC - Publication of full year 2021 results
AnnouncementREG - Allianz Glbl Inv - Top 10 Holdings
AnnouncementREG - GlaxoSmithKline PLC - GSK announces settlement between ViiV and Gilead
AnnouncementREG - GlaxoSmithKline PLC - FDA approves ViiV Healthcare’s sNDA for Cabenuva
AnnouncementREG - GlaxoSmithKline PLC - Total Voting Rights
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
AnnouncementREG - GlaxoSmithKline PLC - Tony Wood appointed CSO Designate, GSK
AnnouncementREG - GlaxoSmithKline PLC - Director/PDMR Shareholding
Announcement